Healthcare Global Enterprises Stock Price To Sales
| HCG Stock | 523.00 21.70 4.33% |
Healthcare Global Enterprises fundamentals help investors to digest information that contributes to Healthcare Global's financial success or failures. It also enables traders to predict the movement of Healthcare Stock. The fundamental analysis module provides a way to measure Healthcare Global's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Healthcare Global stock.
Healthcare | Price To Sales |
Healthcare Global Enterprises Company Price To Sales Analysis
Healthcare Global's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Healthcare Global Price To Sales | 3.42 X |
Most of Healthcare Global's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Healthcare Global Enterprises is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Healthcare Global Enterprises has a Price To Sales of 3.4192 times. This is 84.02% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The price to sales for all India stocks is 70.06% higher than that of the company.
Healthcare Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Healthcare Global's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Healthcare Global could also be used in its relative valuation, which is a method of valuing Healthcare Global by comparing valuation metrics of similar companies.Healthcare Global is currently under evaluation in price to sales category among its peers.
Healthcare Fundamentals
| Return On Equity | 0.0693 | ||||
| Return On Asset | 0.0404 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 85.53 B | ||||
| Shares Outstanding | 139.4 M | ||||
| Shares Owned By Insiders | 71.54 % | ||||
| Shares Owned By Institutions | 14.56 % | ||||
| Price To Book | 8.46 X | ||||
| Price To Sales | 3.42 X | ||||
| Revenue | 18.9 B | ||||
| Gross Profit | 11.2 B | ||||
| EBITDA | 3.5 B | ||||
| Net Income | 677.29 M | ||||
| Cash And Equivalents | 773.02 M | ||||
| Total Debt | 12.74 B | ||||
| Book Value Per Share | 61.80 X | ||||
| Cash Flow From Operations | 2.85 B | ||||
| Earnings Per Share | 4.13 X | ||||
| Target Price | 526.25 | ||||
| Number Of Employees | 6.15 K | ||||
| Beta | 0.3 | ||||
| Market Capitalization | 72.91 B | ||||
| Total Asset | 27.07 B | ||||
| Retained Earnings | (4.96 B) | ||||
| Working Capital | (638.5 M) | ||||
| Net Asset | 27.07 B |
About Healthcare Global Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Healthcare Global Enterprises's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Healthcare Global using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Healthcare Global Enterprises based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Other Information on Investing in Healthcare Stock
Healthcare Global financial ratios help investors to determine whether Healthcare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Healthcare with respect to the benefits of owning Healthcare Global security.